Open Your FREE Demat Account Now!

Anuh Pharma Ltd. Share Price

NSE
BSE

NSE : ANUHPHR

BSE : 506260

Sector : Healthcare

N/A
indicator
1D
1M
3M
6M
1Y
5Y
empty graph

Day's Range

Low

₹81.15

High

₹84.83

Price Summary

Previous Close ₹82.16
Day's Range ₹81.15 - ₹84.83
Open ₹84.35
52 Week Range ₹67.00 - ₹99.50
Volume 66,508
Market Cap ₹0.00
Previous Close ₹82.00
Day's Range ₹82.00 - ₹84.70
Open ₹84.70
52 Week Range ₹66.72 - ₹99.50
Volume 9,797
Market Cap ₹0.00

Stocks Summary

Trade Value ( ₹ in Lacs) 54.64
Market Cap (₹ in Mn) 0.00
Dividend Yield(%) 1.83
Price/Earning (TTM) 17.22
TTM EPS (₹) 4.77
P/E Ratio 16.39
Book Value(₹) 2.29
PAT Margin (%) 5.27
Face Value (₹) 5.00
ROCE(%) 16.02
Trade Value ( ₹ in Lacs) 8.03
Market Cap (₹ in Mn) 0.00
Dividend Yield(%) 1.83
Price/Earning (TTM) 17.22
TTM EPS (₹) 4.77
P/E Ratio 16.39
Book Value(₹) 2.29
PAT Margin (%) 5.27
Face Value (₹) 5.00
ROCE(%) 16.02

Financials

Particulars QTR FY (₹ in Millions) Annual FY (₹ in Millions)
Net sales 1858.83 6615.15
Expenses N/A N/A
PBT 99.2 610.05
Operating profit 0.0 0.0
Net profit 76.12 473.52

Shareholding Pattern

Promoters (% Holding)

71.80%

Mutual funds (% Holding)

0.00%

Non-Institution (% Holding)

28.09%

FI/Banks/Insurance (% Holding)

0.00%

Government (% Holding)

0.00%

FII

0.11%

About Anuh Pharma Ltd.

Founded 1960
NSE Symbol ANUHPHR

Peer Comparision

Stocks Name Market Cap (Cr)(₹) Market Price (₹) 52 Week Low-High (₹)
Sun Pharmaceutical Industries Ltd. 4,37,962.61 1,825.35 1,583.70 - 1,583.70
Divi's Laboratories Ltd. 2,69,450.61 10,150.00 5,647.50 - 5,647.50
Torrent Pharmaceuticals Ltd. 1,79,455.65 4,717.95 3,532.60 - 3,532.60
Laurus Labs Ltd. 1,26,703.22 2,345.00 917.95 - 917.95
Lenskart Solutions Ltd. 1,24,984.87 718.40 0.00 - 0.00
Apollo Hospitals Enterprise Ltd. 1,20,190.31 8,359.05 6,696.50 - 6,696.50
Zydus Lifesciences Ltd. 1,19,341.36 1,196.40 835.50 - 835.50
Dr. Reddy's Laboratories Ltd. 1,13,663.75 1,360.80 1,101.00 - 1,101.00
Cipla Ltd. 1,13,245.71 1,401.75 1,165.70 - 1,165.70
Mankind Pharma Ltd. 1,03,880.84 2,515.00 1,909.70 - 1,909.70
no-content No Records Found

Latest News

Nov
5
2026
EQUITY Posted on Nov 5th 2026

FDC informs about updates

FDC has informed that the Company has received favourable orders from the Assistant Commissioner of Income Tax, Mumbai, for AY 2013-14.
The above information is a part of company’s filings submitted to BSE.
Read More
Nov
5
2026
EQUITY Posted on Nov 5th 2026

Gujarat Kidney And Superspeciality informs about newspaper publication

Pursuant to Regulation 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Gujarat Kidney And Superspeciality has informed that the Company has published the unaudited Standalone and Consolidated Financial Results for the quarter ended on September 30, 2026, in the following Newspapers on November 05, 2026: a. Financial Express (English) b. Gujarat Mitra (Gujarat). A copy of the newspaper advertisement is enclosed.

The above information is a part of company’s filings submitted to BSE. 

Read More
Nov
5
2026
EQUITY Posted on Nov 5th 2026

Kerala Ayurveda informs about board meeting

Kerala Ayurveda has informed that pursuant to Regulation 29 read with Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the meeting of the Board of Directors of the Company is scheduled to be held on Thursday, November 12, 2026, to consider and approve the unaudited financial results (standalone and consolidated) for the quarter and half year ended September 30, 2026. Further, pursuant to the provisions of SEBI (Prohibition of Insider Trading) Regulations, 2015, and Company’s Code of Conduct for Regulating, Monitoring, Preventing and Reporting of Trading in Securities by Insiders and Designated Persons and Immediate Relatives of Designated Persons, the trading window for dealing in the securities of the Company has been closed from September 30, 2026, for the designated persons and will be opened 48 hours after announcement of unaudited financial results for the quarter and half year ended on September 30, 2026.
The above information is a part of company’s filings submitted to BSE. 
Read More
Nov
5
2026
EQUITY Posted on Nov 5th 2026

Mercury Laboratories informs about outcome of board meeting

Mercury Laboratories has informed that the Board of Directors at its meeting held today i.e. on Thursday, November 05, 2026, approved the unaudited financial results of the Company for the quarter and half year ended on September 30, 2026. Accordingly, they enclosed the following: i. Unaudited Financial Results for the quarter and half year ended on September 30, 2026 and, ii. Limited Review Report on the unaudited financial results for the quarter and half year ended on September 30, 2026 by the Statutory Auditors of the Company. The Meeting commenced at 9:30 am (IST) and concluded at 11:15 am (IST).
The above information is a part of company’s filings submitted to BSE.
Read More
Nov
5
2026
EQUITY Posted on Nov 5th 2026

Sigachi Industries informs about transcript of earnings call

In continuation to its letter dated October 31, 2026 audio recording of Q2 FY 2026-27 earnings call, Sigachi Industries has informed that it attached the transcript of the earnings call held on Saturday, October 31, 2026 at 4:30 PM IST. The same is also available on the company's website at www.sigachi.com. 

The above information is a part of company’s filings submitted to BSE. 

Read More
no-content No Records Found

Sign in to Unlock Offers!

Explore Loans, Cards, Investments & Insurance

No SPAM We don't SPAM
Right Hand Side Image
STEP 1/2

Open Demat Account today!

+91

Enter mobile number

Invalid mobile number

Enter Full Name

Invalid Full Name

Verification required
close

Enter the One Time Password (OTP)

Sent to ********99

Edit Number
Enter valid OTP
Field should not be blank
You have exhausted your OTP attempts try again after 10 min

Request another in 60s

Resend OTP

secure   100% safe and secure

Frequently Asked Questions

What is the current share price of Anuh Pharma Ltd. ?

The current share price of Anuh Pharma Ltd. is ₹82.16 as of 2026-11-05.

The market capitalisation of Anuh Pharma Ltd. is ₹822.74 as of 2026-11-05.

The 1-year return of Anuh Pharma Ltd. is -5.98% as of 2026-11-05.

The P/E ratio of Anuh Pharma Ltd. is 16.39 as of 2026-11-05.

The 52-week high and low of Anuh Pharma Ltd. are ₹99.50 and ₹67.00, respectively, as of 2026-11-05.

The dividend yield of Anuh Pharma Ltd. is 1.8273% as of2026-11-05.

You can buy Anuh Pharma Ltd. shares through a registered stockbroker or trading platform. Bajaj Markets partners with trusted brokers to help you open a demat account. This is the first step to trading, making it easier to invest in your desired shares.

The Managing Director of Anuh Pharma Ltd. is .

When investing in a company’s stock, you may consider key factors such as its fundamentals, including financial health, historical performance, and growth potential. Assess the consistency of its performance, market conditions, and industry trends. Additionally, evaluate your own risk tolerance while reviewing aspects like quarterly earnings, management quality, and sector performance, for taking a well-informed decision.

You can track stock performance on online platforms through live market updates, historical charts, and news alerts. Regular analysis and stock alerts allow you to stay informed about significant price changes and events affecting the stock.

Common stock provides voting rights and the potential for dividends based on company performance, while in case of preferred stock, stockholders receive fixed dividends and have priority over common stockholders in asset distribution but generally lack voting rights.

Stock investments carry market risks, including price volatility, economic shifts, and sector-specific issues. Managing risk can involve diversifying your portfolio, setting stop-loss orders, and staying informed about market trends to make timely decisions.

Market capitalisation, or market cap, is the total value of a company’s outstanding shares and is calculated by multiplying the stock price by the total shares. It classifies companies as large-cap, mid-cap, or small-cap, reflecting their size, stability, and potential risk level in the stock market.

View More

Disclaimer

All content and research information displayed on the Site, are obtained from our partner Accord Fintech Private Limited. an authorized data feed vendor of BSE/NSE/MCX/NCDEX exchange. The data is provided on ‘As-Is’ basis and is not a live data feed but a feed with 15 minutes delay or more. Bajaj Markets does not warrant accuracy, completeness, timely availability of the information and data available on the Site. Past performance, when presented, is purely for reference purposes and is not a guarantee of similar future results.

The Services offered on the Site does not constitute investment advice in any manner whatsoever. You shall be solely responsible for any investment decisions made by placing reliance on the information provided on the Site.

Bajaj Markets partners with financial services entities for sourcing leads for services such as DEMAT accounts etc. In case you wish to avail the services, you shall be redirected to partners platform and shall be bound by the terms and conditions, privacy policy governing the said platform. 

Invalid Mobile Number

Invalid Full Name

Home
Home
ONDC_Shopping
Shopping
Loan
Loan Offers
My Accounts
My Accounts
Explore
Explore